US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 1.920
  • -0.030-1.54%
Close Apr 26 16:00 ET
  • 1.900
  • -0.020-1.04%
Post 19:59 ET
100.59MMarket Cap-129P/E (TTM)

Emergent BioSolutions Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-504.99%-206.3M
-65.41%32.1M
181.08%60M
-633.33%-114.4M
-393.30%-184M
-110.65%-34.1M
-71.72%92.8M
-543.11%-74M
47.47%-15.6M
-831.37%-37.3M
Net income from continuing operations
-259.40%-760.5M
26.12%-49.5M
-215.62%-266.7M
-363.30%-261.3M
-4,845.95%-183M
-196.40%-211.6M
-137.66%-67M
-158.41%-84.5M
-1,326.09%-56.4M
-105.31%-3.7M
Operating gains losses
---74.2M
---3.7M
--2M
----
----
----
----
----
----
----
Depreciation and amortization
-12.70%125.1M
-17.09%29.6M
-13.04%28M
-26.07%32.9M
11.97%34.6M
15.75%143.3M
22.26%35.7M
-1.53%32.2M
34.04%44.5M
7.67%30.9M
Deferred tax
68.88%-8.9M
90.39%-5.2M
-71.62%6.5M
-357.14%-1.8M
-542.11%-8.4M
-162.17%-28.6M
-219.16%-54.1M
502.63%22.9M
146.67%700K
211.76%1.9M
Other non cash items
163.36%34.5M
292.59%10.4M
-77.60%2.8M
374.36%18.5M
33.33%2.8M
45.56%13.1M
93.86%-5.4M
-86.29%12.5M
3,800.00%3.9M
-62.50%2.1M
Change In working capital
-3,247.62%-70.3M
-71.85%46.5M
195.46%65.2M
-604.85%-145.2M
53.06%-36.8M
98.55%-2.1M
28.16%165.2M
23.00%-68.3M
73.42%-20.6M
27.21%-78.4M
-Change in receivables
-118.29%-21.6M
3.65%36.9M
574.34%72.1M
-3,410.00%-132.4M
-98.08%1.8M
829.01%118.1M
-63.86%35.6M
81.00%-15.2M
105.21%4M
122.57%93.7M
-Change in inventory
101.05%600K
-43.98%25.6M
95.60%-1.2M
122.83%5.8M
40.92%-29.6M
14.26%-57.1M
631.40%45.7M
-225.81%-27.3M
-225.74%-25.4M
49.85%-50.1M
-Change in prepaid assets
158.79%11.7M
108.33%30M
96.64%-500K
-375.00%-13.3M
72.89%-4.5M
-358.44%-19.9M
-76.96%14.4M
71.56%-14.9M
-136.84%-2.8M
-66.00%-16.6M
-Change in payables and accrued expense
31.90%-55.5M
-170.51%-42.2M
138.46%3M
-118.34%-7.3M
90.81%-9M
-1,098.53%-81.5M
-177.61%-15.6M
-118.62%-7.8M
304.10%39.8M
-98.58%-97.9M
-Change in other working capital
-114.36%-5.5M
-104.47%-3.8M
-164.52%-8.2M
105.52%2M
160.00%4.5M
160.70%38.3M
295.18%85.1M
84.42%-3.1M
-302.22%-36.2M
-179.79%-7.5M
Cash from discontinued investing activities
Operating cash flow
-504.99%-206.3M
-65.41%32.1M
181.08%60M
-633.33%-114.4M
-393.30%-184M
-110.65%-34.1M
-71.72%92.8M
-543.11%-74M
47.47%-15.6M
-831.37%-37.3M
Investing cash flow
Cash flow from continuing investing activities
155.68%212.3M
74.89%-11.4M
93.04%-18.9M
902.80%257.7M
53.11%-15.1M
-70.15%-381.3M
0.87%-45.4M
-392.03%-271.6M
52.09%-32.1M
42.60%-32.2M
Net PPE purchase and sale
55.44%-51.6M
51.69%-11.4M
54.84%-12.6M
61.06%-12.5M
53.11%-15.1M
48.33%-115.8M
48.47%-23.6M
49.46%-27.9M
52.09%-32.1M
42.60%-32.2M
Net business purchase and sale
--270.2M
--0
--0
----
----
--0
--0
--0
----
----
Net other investing changes
97.63%-6.3M
--0
----
----
----
---265.5M
---21.8M
----
----
----
Cash from discontinued investing activities
Investing cash flow
155.68%212.3M
74.89%-11.4M
93.04%-18.9M
902.80%257.7M
53.11%-15.1M
-70.15%-381.3M
0.87%-45.4M
-392.03%-271.6M
52.09%-32.1M
42.60%-32.2M
Financing cash flow
Cash flow from continuing financing activities
-211.33%-535.7M
-98.67%4.7M
-118.75%-43M
-1,485.99%-486.9M
85.11%-10.5M
441.28%481.2M
420.42%353.1M
4,686.00%229.3M
-707.89%-30.7M
-220.45%-70.5M
Net issuance payments of debt
-196.31%-543.4M
-98.83%4.1M
-118.68%-42.9M
-5,807.14%-496.2M
1.18%-8.4M
1,671.59%564.2M
4,284.52%351.5M
4,200.00%229.6M
-47.37%-8.4M
47.53%-8.5M
Net common stock issuance
110.23%8.4M
200.00%200K
--0
133.61%8.2M
--0
22.55%-82.1M
99.81%-200K
--0
---24.4M
---57.5M
Proceeds from stock option exercised by employees
-64.00%1.8M
-75.00%500K
--0
-48.00%1.3M
--0
-68.55%5M
-41.18%2M
--0
-19.35%2.5M
-92.75%500K
Net other financing activities
57.63%-2.5M
50.00%-100K
66.67%-100K
50.00%-200K
58.00%-2.1M
60.67%-5.9M
-120.00%-200K
84.21%-300K
66.67%-400K
61.24%-5M
Cash from discontinued financing activities
Financing cash flow
-211.33%-535.7M
-98.67%4.7M
-118.75%-43M
-1,485.99%-486.9M
85.11%-10.5M
441.28%481.2M
421.00%353.1M
4,686.00%229.3M
-707.89%-30.7M
-217.57%-70.5M
Net cash flow
Beginning cash position
11.50%642.6M
-63.57%87.8M
-75.27%88.6M
-1.33%430.2M
11.50%642.6M
-7.27%576.3M
-40.35%241M
-19.97%358.3M
-20.44%436M
-7.27%576.3M
Current changes in cash
-905.02%-529.7M
-93.66%25.4M
98.37%-1.9M
-338.27%-343.6M
-49.71%-209.6M
246.55%65.8M
132.44%400.5M
-167.36%-116.3M
21.99%-78.4M
-91.26%-140M
Effect of exchange rate changes
-340.00%-1.2M
-236.36%-1.5M
210.00%1.1M
-185.71%-600K
33.33%-200K
266.67%500K
--1.1M
-400.00%-1M
250.00%700K
0.00%-300K
End cash Position
-82.62%111.7M
-82.62%111.7M
-63.57%87.8M
-75.27%88.6M
-1.33%430.2M
11.50%642.6M
11.50%642.6M
-40.35%241M
-19.97%358.3M
-20.44%436M
Free cash flow
-72.05%-257.9M
-70.09%20.7M
146.52%47.4M
-166.04%-126.9M
-186.47%-199.1M
-255.98%-149.9M
-75.49%69.2M
-164.68%-101.9M
50.67%-47.7M
-36.27%-69.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -504.99%-206.3M-65.41%32.1M181.08%60M-633.33%-114.4M-393.30%-184M-110.65%-34.1M-71.72%92.8M-543.11%-74M47.47%-15.6M-831.37%-37.3M
Net income from continuing operations -259.40%-760.5M26.12%-49.5M-215.62%-266.7M-363.30%-261.3M-4,845.95%-183M-196.40%-211.6M-137.66%-67M-158.41%-84.5M-1,326.09%-56.4M-105.31%-3.7M
Operating gains losses ---74.2M---3.7M--2M----------------------------
Depreciation and amortization -12.70%125.1M-17.09%29.6M-13.04%28M-26.07%32.9M11.97%34.6M15.75%143.3M22.26%35.7M-1.53%32.2M34.04%44.5M7.67%30.9M
Deferred tax 68.88%-8.9M90.39%-5.2M-71.62%6.5M-357.14%-1.8M-542.11%-8.4M-162.17%-28.6M-219.16%-54.1M502.63%22.9M146.67%700K211.76%1.9M
Other non cash items 163.36%34.5M292.59%10.4M-77.60%2.8M374.36%18.5M33.33%2.8M45.56%13.1M93.86%-5.4M-86.29%12.5M3,800.00%3.9M-62.50%2.1M
Change In working capital -3,247.62%-70.3M-71.85%46.5M195.46%65.2M-604.85%-145.2M53.06%-36.8M98.55%-2.1M28.16%165.2M23.00%-68.3M73.42%-20.6M27.21%-78.4M
-Change in receivables -118.29%-21.6M3.65%36.9M574.34%72.1M-3,410.00%-132.4M-98.08%1.8M829.01%118.1M-63.86%35.6M81.00%-15.2M105.21%4M122.57%93.7M
-Change in inventory 101.05%600K-43.98%25.6M95.60%-1.2M122.83%5.8M40.92%-29.6M14.26%-57.1M631.40%45.7M-225.81%-27.3M-225.74%-25.4M49.85%-50.1M
-Change in prepaid assets 158.79%11.7M108.33%30M96.64%-500K-375.00%-13.3M72.89%-4.5M-358.44%-19.9M-76.96%14.4M71.56%-14.9M-136.84%-2.8M-66.00%-16.6M
-Change in payables and accrued expense 31.90%-55.5M-170.51%-42.2M138.46%3M-118.34%-7.3M90.81%-9M-1,098.53%-81.5M-177.61%-15.6M-118.62%-7.8M304.10%39.8M-98.58%-97.9M
-Change in other working capital -114.36%-5.5M-104.47%-3.8M-164.52%-8.2M105.52%2M160.00%4.5M160.70%38.3M295.18%85.1M84.42%-3.1M-302.22%-36.2M-179.79%-7.5M
Cash from discontinued investing activities
Operating cash flow -504.99%-206.3M-65.41%32.1M181.08%60M-633.33%-114.4M-393.30%-184M-110.65%-34.1M-71.72%92.8M-543.11%-74M47.47%-15.6M-831.37%-37.3M
Investing cash flow
Cash flow from continuing investing activities 155.68%212.3M74.89%-11.4M93.04%-18.9M902.80%257.7M53.11%-15.1M-70.15%-381.3M0.87%-45.4M-392.03%-271.6M52.09%-32.1M42.60%-32.2M
Net PPE purchase and sale 55.44%-51.6M51.69%-11.4M54.84%-12.6M61.06%-12.5M53.11%-15.1M48.33%-115.8M48.47%-23.6M49.46%-27.9M52.09%-32.1M42.60%-32.2M
Net business purchase and sale --270.2M--0--0----------0--0--0--------
Net other investing changes 97.63%-6.3M--0---------------265.5M---21.8M------------
Cash from discontinued investing activities
Investing cash flow 155.68%212.3M74.89%-11.4M93.04%-18.9M902.80%257.7M53.11%-15.1M-70.15%-381.3M0.87%-45.4M-392.03%-271.6M52.09%-32.1M42.60%-32.2M
Financing cash flow
Cash flow from continuing financing activities -211.33%-535.7M-98.67%4.7M-118.75%-43M-1,485.99%-486.9M85.11%-10.5M441.28%481.2M420.42%353.1M4,686.00%229.3M-707.89%-30.7M-220.45%-70.5M
Net issuance payments of debt -196.31%-543.4M-98.83%4.1M-118.68%-42.9M-5,807.14%-496.2M1.18%-8.4M1,671.59%564.2M4,284.52%351.5M4,200.00%229.6M-47.37%-8.4M47.53%-8.5M
Net common stock issuance 110.23%8.4M200.00%200K--0133.61%8.2M--022.55%-82.1M99.81%-200K--0---24.4M---57.5M
Proceeds from stock option exercised by employees -64.00%1.8M-75.00%500K--0-48.00%1.3M--0-68.55%5M-41.18%2M--0-19.35%2.5M-92.75%500K
Net other financing activities 57.63%-2.5M50.00%-100K66.67%-100K50.00%-200K58.00%-2.1M60.67%-5.9M-120.00%-200K84.21%-300K66.67%-400K61.24%-5M
Cash from discontinued financing activities
Financing cash flow -211.33%-535.7M-98.67%4.7M-118.75%-43M-1,485.99%-486.9M85.11%-10.5M441.28%481.2M421.00%353.1M4,686.00%229.3M-707.89%-30.7M-217.57%-70.5M
Net cash flow
Beginning cash position 11.50%642.6M-63.57%87.8M-75.27%88.6M-1.33%430.2M11.50%642.6M-7.27%576.3M-40.35%241M-19.97%358.3M-20.44%436M-7.27%576.3M
Current changes in cash -905.02%-529.7M-93.66%25.4M98.37%-1.9M-338.27%-343.6M-49.71%-209.6M246.55%65.8M132.44%400.5M-167.36%-116.3M21.99%-78.4M-91.26%-140M
Effect of exchange rate changes -340.00%-1.2M-236.36%-1.5M210.00%1.1M-185.71%-600K33.33%-200K266.67%500K--1.1M-400.00%-1M250.00%700K0.00%-300K
End cash Position -82.62%111.7M-82.62%111.7M-63.57%87.8M-75.27%88.6M-1.33%430.2M11.50%642.6M11.50%642.6M-40.35%241M-19.97%358.3M-20.44%436M
Free cash flow -72.05%-257.9M-70.09%20.7M146.52%47.4M-166.04%-126.9M-186.47%-199.1M-255.98%-149.9M-75.49%69.2M-164.68%-101.9M50.67%-47.7M-36.27%-69.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg